levofloxacin has been researched along with Cronobacter Infections in 32 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (18.75) | 29.6817 |
| 2010's | 24 (75.00) | 24.3611 |
| 2020's | 2 (6.25) | 2.80 |
| Authors | Studies |
|---|---|
| Cauda, R; Citton, R; D'Inzeo, T; Fadda, G; Fiori, B; Montuori, E; Posteraro, B; Sanguinetti, M; Spanu, T; Trecarichi, EM; Tumbarello, M | 1 |
| Andres, P; Centrón, D; Galas, M; Guerriero, L; Petroni, A; Quiroga, C; Quiroga, MP; Soler Bistué, AJ; Tokumoto, M; Tolmasky, ME; Vargas, LJ; Zorreguieta, A | 1 |
| Chen, H; Chen, M; Wang, H; Yang, H; Yang, Q | 1 |
| Chen, Z; Deng, Y; Huang, L; Liu, J; Lü, D; Ma, J; Wang, M; Wang, X; Xu, X; Zeng, Z; Zhang, Y | 1 |
| Guo, Q; Hooper, DC; Wang, M; Wang, X; Wu, S; Xu, X; Ye, X | 1 |
| Flamm, R; Friedland, I; Kaniga, K; Lee, M; Redman, R; Tong, SY | 1 |
| Hong, MY; Hsieh, CC; Ko, WC; Lee, CC; Lee, CH; Tang, HJ; Yang, CY | 1 |
| Brites, MM; Calado, R; Cardoso, JC; Relvas, M | 1 |
| Huang, J; Liu, F; Xiong, H; Xu, Q; Yang, J | 1 |
| Aguilar-Rivera, LR; Carrizales-Sepúlveda, EF; Gómez-Quiroz, RA; González-Aguirre, JE; Jiménez-Castillo, RA; Llantada-López, AR; Náñez-Terreros, H; Rendón-Ramírez, EJ | 1 |
| Tsuchida, Y; Yoshida, N | 1 |
| Combs, N; Elliott, K; Kalaria, SS; Phillips, LG | 1 |
| Accame, L; Bandettini, R; Buffa, P; Castagnola, E; Della Casa Alberighi, O; Garaventa, A; Loy, A; Naselli, A | 1 |
| Baker, TM; Chavda, KD; Chen, L; Fowler, VG; Jacobs, SE; Jenkins, SG; Kreiswirth, BN; Satlin, MJ; Schuetz, AN; Shashkina, E; Shore, TB; Small, CB; Soave, R; van Besien, K; Walsh, TJ; Westblade, LF | 1 |
| Ebihara, Y; Imai, K; Kodana, M; Maeda, T; Maesaki, S; Mitsutake, K; Murakami, T; Sakai, J; Taji, Y; Tarumoto, N; Watanabe, N; Yamaguchi, T | 1 |
| Chen, PL; Hung, YP; Ko, WC; Lee, NY; Li, CW; Li, MC; Liu, CC; Syue, LS; Tang, HJ; Tsai, PF | 1 |
| Asai, N; Hagihara, M; Kato, H; Koizumi, Y; Mikamo, H; Sakanashi, D; Shiota, A; Suematsu, H; Watanabe, H; Yamada, A; Yamagishi, Y | 1 |
| Briggs, H; Burguete, SR; Cardile, AP; Herrera, M; Jorgensen, JH; Wickes, BL | 1 |
| Arakawa, H; Kajihara, M; Kato, K; Koido, S; Mitobe, J; Odahara, S; Ohkusa, T; Shimamoto, N; Tajiri, H; Takakura, K; Tsukinaga, S; Uchiyama, K; Yukawa, T | 1 |
| Jia, XQ; Li, YH; Pang, F; Wang, B; Zhao, QG | 1 |
| Popov, SV | 1 |
| Gergis, U; Jacobs, SE; Mark, TM; Satlin, MJ; Shore, TB; Soave, R; Vardhana, S; Walsh, TJ | 1 |
| Crandon, JL; Ghazi, IM; Lesho, EP; McGann, P; Nicolau, DP | 1 |
| Badal, RE; Cao, B; Chen, S; Chu, Y; Duan, Q; Feng, X; Gui, B; Hu, B; Hu, Z; Huang, W; Kong, H; Liao, K; Luo, Y; Ni, Y; Shao, H; Su, J; Sun, Z; Wang, Y; Wu, A; Xu, Y; Yang, Q; Yu, Y; Zhang, H; Zhang, S | 1 |
| Bliss, C; Cloutier, DJ; Goldstein, EJ; Huntington, JA; Sakoulas, G; Steenbergen, JN; Umeh, O | 1 |
| Fu, Y; Liu, R; Pan, Z; Zhang, P; Zhou, H; Zhou, J | 1 |
| Armstrong, ES; Bliss, CA; Cloutier, DJ; Mikulca, JA; Steenbergen, JN | 1 |
| Chatzikonstantinou, M; Galani, I; Margaritis, A; Petrikkos, G; Souli, M | 1 |
| Chen, S; Hu, F; Hu, L; Li, T; Li, X; Shao, Y; Shen, J; Xiong, Z | 1 |
| Chen, YH; Chen, YS; Chuang, YC; Ho, CM; Hsueh, PR; Huang, CC; Ko, WC; Lee, YL; Liu, CE; Liu, YC; Liu, YM; Lu, PL; Tang, HJ; Toh, HS; Wang, JH; Yu, KW | 1 |
| Chen, PL; Hung, YP; Ko, WC; Wu, YH | 1 |
| Marchetti, F; Trinchieri, A | 1 |
3 review(s) available for levofloxacin and Cronobacter Infections
| Article | Year |
|---|---|
Enterobacter cloacae infection of the shoulder in a 52-year-old woman without apparent predisposing risk factor: a case report and literature review.
Topics: Anti-Bacterial Agents; Arthritis, Infectious; Debridement; Delayed Diagnosis; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Follow-Up Studies; Humans; Immunocompromised Host; Levofloxacin; Magnetic Resonance Imaging; Middle Aged; Shoulder; Shoulder Pain; Treatment Outcome | 2021 |
Pantoea dispersa bacteremia in an immunocompetent patient: a case report and review of the literature.
Topics: Acute Disease; Adult; Anti-Bacterial Agents; Bacteremia; Bile Ducts; Cholangitis; Enterobacteriaceae Infections; Female; Humans; Immunocompetence; Immunocompromised Host; Levofloxacin; Meropenem; Pantoea | 2019 |
[Rational antimicrobial therapy of chronic bacterial prostatitis].
Topics: Adult; Anti-Bacterial Agents; Chronic Disease; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Prostate; Prostatitis; Staphylococcal Infections; Staphylococcus; Treatment Outcome | 2013 |
3 trial(s) available for levofloxacin and Cronobacter Infections
| Article | Year |
|---|---|
Efficacy of ceftolozane/tazobactam versus levofloxacin in the treatment of complicated urinary tract infections (cUTIs) caused by levofloxacin-resistant pathogens: results from the ASPECT-cUTI trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamase Inhibitors; Cephalosporins; Double-Blind Method; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Female; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Tazobactam; Treatment Outcome; Urinary Tract Infections; Young Adult | 2016 |
Outcomes of high-dose levofloxacin therapy remain bound to the levofloxacin minimum inhibitory concentration in complicated urinary tract infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Infective Agents, Urinary; Cephalosporins; Dose-Response Relationship, Drug; Drug Administration Schedule; Enterobacteriaceae Infections; Female; Follow-Up Studies; Humans; Injections, Intravenous; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Penicillanic Acid; Recurrence; Tazobactam; Treatment Outcome; Urinary Tract Infections; Young Adult | 2016 |
[Multicentric study for evaluation of levofloxacin in the treatment of complicated urinary tract infections].
Topics: Anti-Infective Agents; Drug Administration Schedule; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Follow-Up Studies; Humans; Levofloxacin; Ofloxacin; Pseudomonas Infections; Recurrence; Safety; Staphylococcal Infections; Streptococcal Infections; Superinfection; Treatment Outcome; Urinary Tract; Urinary Tract Infections | 2003 |
26 other study(ies) available for levofloxacin and Cronobacter Infections
| Article | Year |
|---|---|
Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Cross Infection; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Female; Humans; Klebsiella pneumoniae; Male; Microbial Sensitivity Tests; Middle Aged; Predictive Value of Tests; Proteus mirabilis; Risk Factors; Survival Analysis; Treatment Outcome | 2007 |
Complex class 1 integrons with diverse variable regions, including aac(6')-Ib-cr, and a novel allele, qnrB10, associated with ISCR1 in clinical enterobacterial isolates from Argentina.
Topics: Alleles; Amino Acid Sequence; Argentina; Bacterial Proteins; Base Sequence; beta-Lactamases; Cross Infection; DNA Transposable Elements; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Integrons; Microbial Sensitivity Tests; Molecular Sequence Data; Polymerase Chain Reaction; Sequence Analysis, DNA; Sequence Homology, Nucleic Acid | 2007 |
High prevalence of plasmid-mediated quinolone resistance genes qnr and aac(6')-Ib-cr in clinical isolates of Enterobacteriaceae from nine teaching hospitals in China.
Topics: Acetyltransferases; Anti-Bacterial Agents; Bacterial Proteins; China; Conjugation, Genetic; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Hospitals, Teaching; Humans; Microbial Sensitivity Tests; Plasmids; Polymerase Chain Reaction; Prevalence; Quinolones | 2008 |
High prevalence of plasmid-mediated quinolone resistance determinants qnr, aac(6')-Ib-cr, and qepA among ceftiofur-resistant Enterobacteriaceae isolates from companion and food-producing animals.
Topics: Acetyltransferases; Adolescent; Adult; Aged; Animals; Animals, Domestic; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Cambodia; Cephalosporins; China; Conjugation, Genetic; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli Proteins; Female; Humans; Male; Mali; Microbial Sensitivity Tests; Middle Aged; Nasal Cavity; Plasmids; Quinolones; Young Adult | 2009 |
New plasmid-mediated quinolone resistance gene, qnrC, found in a clinical isolate of Proteus mirabilis.
Topics: Amino Acid Sequence; Anti-Infective Agents; Bacterial Proteins; Base Sequence; Conjugation, Genetic; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Plasmids; Polymerase Chain Reaction; Proteus Infections; Proteus mirabilis; Quinolones; Sequence Analysis, DNA | 2009 |
Worldwide experience with the use of doripenem against extended-spectrum-beta-lactamase-producing and ciprofloxacin-resistant Enterobacteriaceae: analysis of six phase 3 clinical studies.
Topics: Anti-Bacterial Agents; beta-Lactam Resistance; Carbapenems; Ciprofloxacin; Clinical Trials, Phase III as Topic; Doripenem; Enterobacteriaceae; Enterobacteriaceae Infections; Global Health; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Prevalence | 2010 |
Clinical Benefit of Empiric High-Dose Levofloxacin Therapy for Adults With Community-onset Enterobacteriaceae Bacteremia.
Topics: Aged; Anti-Bacterial Agents; Bacteremia; Cohort Studies; Community-Acquired Infections; Comorbidity; Enterobacteriaceae Infections; Female; Humans; Length of Stay; Levofloxacin; Male; Neoplasms; Retrospective Studies | 2019 |
Acute retiform purpura caused by
Topics: Acute Disease; Aged, 80 and over; Anti-Bacterial Agents; Bandages; Disseminated Intravascular Coagulation; Enterobacteriaceae Infections; Humans; Levofloxacin; Male; Morganella morganii; Purpura; Skin Diseases, Bacterial | 2019 |
A case of round pneumonia due to Enterobacter hormaechei: the need for a standardized diagnosis and treatment approach in adults.
Topics: Adult; Aged; Anti-Bacterial Agents; Cough; Dyspnea; Enterobacter; Enterobacteriaceae Infections; Humans; Levofloxacin; Lung; Male; Pneumonia; Sputum; Treatment Outcome | 2021 |
Palm atheroma infection caused by
Topics: Aged; Anti-Bacterial Agents; Ceftriaxone; Drainage; Enterobacteriaceae; Enterobacteriaceae Infections; Hand; Humans; Levofloxacin; Male; Plaque, Atherosclerotic | 2017 |
Raoultella planticola: A Rare Cause of Wound Infection.
Topics: Aged; Anti-Bacterial Agents; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Levofloxacin; Wound Infection | 2017 |
Granulated sugar for adjuvant treatment of surgical wound infection due to multi-drug-resistant pathogens in a child with sarcoma: a case report and literature review.
Topics: Administration, Topical; Child; Combined Modality Therapy; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Immunocompromised Host; Levofloxacin; Male; Meropenem; Neurilemmoma; Soft Tissue Neoplasms; Sucrose; Surgical Wound Infection; Thienamycins; Wound Healing | 2017 |
Colonization With Levofloxacin-resistant Extended-spectrum β-Lactamase-producing Enterobacteriaceae and Risk of Bacteremia in Hematopoietic Stem Cell Transplant Recipients.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; Bacterial Typing Techniques; beta-Lactamases; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Gastrointestinal Tract; Hematopoietic Stem Cell Transplantation; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Multilocus Sequence Typing; Neutropenia; Prospective Studies; Risk Factors | 2018 |
First report of the isolation of bla
Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carbapenems; Cephalosporins; Colistin; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Japan; Levofloxacin; Microbial Sensitivity Tests | 2018 |
Bloodstream infections in hospitalized adults with dengue fever: Clinical characteristics and recommended empirical therapy.
Topics: Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Candidemia; Cefepime; Coinfection; Dengue; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Escherichia coli Infections; Female; Hospitals; Humans; Levofloxacin; Male; Microbial Sensitivity Tests; Middle Aged; Mortality; Piperacillin, Tazobactam Drug Combination; Retrospective Studies; Risk Factors; Staphylococcal Infections; Streptococcus; Taiwan | 2019 |
Treatment of KPC-2 Enterobacter cloacae empyema with cefepime and levofloxacin.
Topics: Anti-Bacterial Agents; beta-Lactamases; Cefepime; Cephalosporins; Drug Therapy, Combination; Empyema; Enterobacter cloacae; Enterobacteriaceae Infections; Humans; Levofloxacin; Male; Middle Aged; Treatment Outcome | 2014 |
Edwardsiella tarda superinfection in relapse of ulcerative colitis.
Topics: Adult; Anti-Bacterial Agents; Colitis, Ulcerative; Edwardsiella tarda; Enterobacteriaceae Infections; Feces; Female; Humans; Levofloxacin; Male; Middle Aged; Recurrence; Severity of Illness Index; Superinfection; Young Adult | 2014 |
Control of an outbreak due to orthopedic infections caused by Enterobacteriaceae producing IMP-4 or IMP-8 carbapenemases.
Topics: Adolescent; Anti-Bacterial Agents; Arthritis, Infectious; beta-Lactam Resistance; beta-Lactamases; China; Cross Infection; Disease Outbreaks; Drug Resistance, Multiple, Bacterial; Enterobacter cloacae; Enterobacteriaceae Infections; Female; Fluoroquinolones; Fracture Fixation, Internal; Humans; Infection Control; Klebsiella Infections; Klebsiella oxytoca; Levofloxacin; Male; Meropenem; Middle Aged; Osteitis; Patient Isolation; Protective Clothing; Retrospective Studies; Surgical Wound Infection; Thienamycins; Universal Precautions; Wound Infection | 2014 |
Impact of Prophylactic Levofloxacin on Rates of Bloodstream Infection and Fever in Neutropenic Patients with Multiple Myeloma Undergoing Autologous Hematopoietic Stem Cell Transplantation.
Topics: Antibiotic Prophylaxis; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; Clostridioides difficile; Clostridium Infections; Combined Modality Therapy; Drug Resistance, Microbial; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Febrile Neutropenia; Female; Filgrastim; Guideline Adherence; Hematopoietic Stem Cell Transplantation; Humans; Immunocompromised Host; Incidence; Levofloxacin; Lymphoma; Male; Melphalan; Middle Aged; Multiple Myeloma; Practice Guidelines as Topic; Retrospective Studies; Risk Factors; Transplantation Conditioning; Transplantation, Autologous | 2015 |
Efficacy of humanized high-dose meropenem, cefepime, and levofloxacin against Enterobacteriaceae isolates producing Verona integron-encoded metallo-β-lactamase (VIM) in a murine thigh infection model.
Topics: Animals; Anti-Infective Agents; Bacterial Proteins; beta-Lactamases; Cefepime; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Levofloxacin; Meropenem; Mice; Microbial Sensitivity Tests; Thienamycins; Thigh | 2015 |
Antimicrobial Susceptibilities of Aerobic and Facultative Gram-Negative Bacilli from Intra-abdominal Infections in Patients from Seven Regions in China in 2012 and 2013.
Topics: Amikacin; Ampicillin; Anti-Bacterial Agents; beta-Lactamases; beta-Lactams; Cefoxitin; China; Ciprofloxacin; Community-Acquired Infections; Cross Infection; Drug Resistance, Multiple, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Ertapenem; Gene Expression; Humans; Imipenem; Intraabdominal Infections; Levofloxacin; Microbial Sensitivity Tests; Penicillanic Acid; Piperacillin; Piperacillin, Tazobactam Drug Combination; Sulbactam | 2016 |
Combination of Tigecycline and Levofloxacin for Successful Treatment of Nosocomial Pneumonia Caused by New Delhi Metallo-β-Lactamase-1-Producing Raoultella planticola.
Topics: Aged; Anti-Bacterial Agents; beta-Lactam Resistance; beta-Lactamases; Carbapenems; Cross Infection; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Enterobacteriaceae; Enterobacteriaceae Infections; Feces; Gene Expression; Humans; Levofloxacin; Male; Minocycline; Plasmids; Polymerase Chain Reaction; Sputum; Tigecycline; Treatment Outcome | 2017 |
Plasmid-mediated quinolone resistance determinants among Gram-negative bacteraemia isolates: a hidden threat.
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactamases; Ciprofloxacin; DNA Gyrase; DNA Topoisomerase IV; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Escherichia coli; Gram-Negative Bacterial Infections; Greece; Humans; Levofloxacin; Microbial Sensitivity Tests; Mutation; Quinolones; R Factors; Stenotrophomonas maltophilia | 2017 |
Prevalence of plasmid-mediated quinolone resistance determinants in Citrobacter freundii isolates from Anhui province, PR China.
Topics: China; Ciprofloxacin; Citrobacter freundii; Conjugation, Genetic; Drug Resistance, Bacterial; Enterobacteriaceae Infections; Humans; Levofloxacin; Microbial Sensitivity Tests; Molecular Sequence Data; Ofloxacin; Plasmids | 2011 |
Antimicrobial susceptibility profiles of Gram-negative bacilli isolated from patients with hepatobiliary infections in Taiwan: results from the Study for Monitoring Antimicrobial Resistance Trends (SMART), 2006-2010.
Topics: Anti-Bacterial Agents; beta-Lactamases; Ceftazidime; Ciprofloxacin; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Gallbladder Diseases; Hospitalization; Humans; Levofloxacin; Liver Diseases; Microbial Sensitivity Tests; Ofloxacin; Population Surveillance; Practice Guidelines as Topic; Prevalence; Prospective Studies; Pseudomonas aeruginosa; Taiwan; Time Factors | 2012 |
Risk factors and clinical impact of levofloxacin or cefazolin nonsusceptibility or ESBL production among uropathogens in adults with community-onset urinary tract infections.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactamases; Cefazolin; Community-Acquired Infections; Comorbidity; Drug Resistance, Bacterial; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Levofloxacin; Male; Middle Aged; Prospective Studies; Risk Factors; Taiwan; Urinary Tract Infections; Young Adult | 2014 |